We further investigated potential associations between SBCs and breast cancer risk by assessing the enrichment of the SBC signature in sets of genes differentially expressed in CD44+ progenitor-enriched cells between nulliparous relative to parous women and BRCA1/2mut carriers relative to non-carriers6. The gene discussed is BRCA1; the disease is breast cancer.